- Home
- ALGS vs SPPL Comparison
ALGS vs SPPL Comparison
Compare ALGS & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALGS | SPPL |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 37.0M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALGS | SPPL |
|---|---|---|
| Price | $5.58 | $2.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $52.38 | N/A |
| AVG Volume (30 Days) | 39.1K | ★ 48.8K |
| Earning Date | 11-05-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $1,562.10 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.98 | $1.50 |
| 52 Week High | $13.69 | $7.00 |
Technical Indicators
Market Signals| Indicator | ALGS | SPPL |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 44.43 |
| Support Level | $4.81 | $1.60 |
| Resistance Level | $6.12 | $2.47 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 58.78 | 34.07 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.